Gene therapy based precision medicine therapeutics: Clinical pharmacology & translational science considerations
The era of gene therapy may have started a couple of decades ago, but approvals…
Certara2021 年 8 月 13 日
Application of Quantitative Systems Pharmacology to guide the optimal dosing of COVID-19 vaccines
Optimal use and distribution of coronavirus disease 2019 (COVID-19) vaccines involves adjustments of dosing. Due…
Certara2021 年 7 月 31 日
Maximizing oligonucleotide therapeutic development: Pre-clinical and translational considerations
This is the second of three blog posts discussing best practices for developing oligonucleotide therapeutics.…
Certara2021 年 6 月 25 日
Maximizing oligonucleotide therapeutic development: How they work
This is the first of three blog posts discussing best practices for developing oligonucleotides. Interest…
Certara2021 年 5 月 7 日
The Promises and Pitfalls of Gene Therapy for Rare Diseases
The state of gene therapy faces much uncertainty as recent regulatory and clinical setbacks have…
Certara2021 年 4 月 29 日
Early Value Assessment in Gene Therapy Clinical Trial Design
A global biotechnology company engineering precision genetic medicine for rare diseases was in need of…
Certara2021 年 2 月 12 日
8 tips for successfully developing oligonucleotide therapies
By Eva Gil Berglund and Nathalie H Gosselin Oligonucleotide therapeutics are a validated class of…
Certara2021 年 2 月 1 日
